Miller, A. M. (2011) Role of IL-33 in inflammation and disease. Journal of Inflammation, 8(1), p. 22. (doi: 10.1186/1476-9255-8-22)
|
Text
57253.pdf - Published Version Available under License Creative Commons Attribution. 4MB |
Publisher's URL: http://dx.doi.org/10.1186/1476-9255-8-22
Abstract
Interleukin (IL)-33 is a new member of the IL-1 superfamily of cytokines that is expressed by mainly stromal cells, such as epithelial and endothelial cells, and its expression is upregulated following pro-inflammatory stimulation. IL-33 can function both as a traditional cytokine and as a nuclear factor regulating gene transcription. It is thought to function as an 'alarmin' released following cell necrosis to alerting the immune system to tissue damage or stress. It mediates its biological effects via interaction with the receptors ST2 (IL-1RL1) and IL-1 receptor accessory protein (IL-1RAcP), both of which are widely expressed, particularly by innate immune cells and T helper 2 (Th2) cells. IL-33 strongly induces Th2 cytokine production from these cells and can promote the pathogenesis of Th2-related disease such as asthma, atopic dermatitis and anaphylaxis. However, IL-33 has shown various protective effects in cardiovascular diseases such as atherosclerosis, obesity, type 2 diabetes and cardiac remodeling. Thus, the effects of IL-33 are either pro-or anti-inflammatory depending on the disease and the model. In this review the role of IL-33 in the inflammation of several disease pathologies will be discussed, with particular emphasis on recent advances.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Miller, Dr Ashley |
| Authors: | Miller, A. M. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
| Journal Name: | Journal of Inflammation |
| Publisher: | BioMed Central |
| ISSN: | 1476-9255 |
| ISSN (Online): | 1476-9255 |
| Published Online: | 26 August 2011 |
| Copyright Holders: | Copyright © 2013 The Author |
| First Published: | First published in Journal of Inflammation 8(1):22 |
| Publisher Policy: | Reproduced under a Creative Commons License |
| Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information